Maria Ángelés Solinís

Author

Also Known As

Angeles, M., M A Solinís, M. A. Solinis, M. A. Solinís, M. Angeles Solinís, M. Ángeles Solinís, M.A Solinı́s, M.A. Solinis, M.A. Solinís, M.A. Solinı́s

111

Publications

4.5K

Citations

H-Index

104

Concepts

All Affiliations

University of the Basque Country Hospital Universitario Araba Osakidetza Hospital Santiago Apostol University of Turin

MÁ

About

Maria Ángelés Solinís is an author at University of the Basque Country specializing in medicine, nanomedicine, and engineering.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	22	26	1.3K
2	Engineering	21	23	1.5K
3	Biochemistry	3	3	139
4	Health Sciences	2	2	25
5	Natural Sciences	1	1	24

Maria Ángelés Solinís

Publications

2.3K

Citations

H-Index

Page 1

	Year	Citations
Budesonide-loaded nanostructured lipid carriers reduce inflammation in murine DSS-induced colitis Ana Beloqui, Régis Coco, Mireille Alhouayek, International Journal of Pharmaceutics InflammationNanomedicineMurine Dss-induced ColitisAnti-inflammatoryMedicine	2013	144
Short- and long-term stability study of lyophilized solid lipid nanoparticles for gene therapy Ana del Pozo‐Rodríguez, Maria Ángelés Solinís, Alicia Rodríguez‐Gascón, European Journal of Pharmaceutics and Biopharmaceutics NanoparticlesNanomedicineGene TherapiesLipid PreparationEngineering	2008	129
A proline-rich peptide improves cell transfection of solid lipid nanoparticle-based non-viral vectors Ana del Pozo‐Rodríguez, Sílvia Pujals, Diego Delgado, Journal of Controlled Release Proline-rich PeptideEngineeringPeptide EngineeringNano-drug DeliveryBiomedical Engineering	2008	106
Solid lipid nanoparticles for retinal gene therapy: Transfection and intracellular trafficking in RPE cells Ana del Pozo‐Rodríguez, Diego Delgado, Maria Ángelés Solinís, International Journal of Pharmaceutics Cell-based Drug DeliveryNanomedicineGene TherapiesRetinal Gene TherapyEngineering	2008	103
A novel gene therapy vector based on hyaluronic acid and solid lipid nanoparticles for ocular diseases Paola S. Apaolaza, Diego Delgado, Ana del Pozo‐Rodríguez, International Journal of Pharmaceutics Tissue EngineeringNanomedicineGene TherapiesEngineeringOcular Diseases	2014	102
Solid lipid nanoparticles: Formulation factors affecting cell transfection capacity Ana del Pozo‐Rodríguez, Diego Delgado, Maria Ángelés Solinís, International Journal of Pharmaceutics NanoparticlesEngineeringSolid Lipid NanoparticlesNano-drug DeliveryBiomedical Engineering	2007	98
Understanding the mechanism of protamine in solid lipid nanoparticle-based lipofection: The importance of the entry pathway Diego Delgado, Ana del Pozo‐Rodríguez, Maria Ángelés Solinís, European Journal of Pharmaceutics and Biopharmaceutics NanoparticlesNanomedicineLipid PreparationEngineeringBiochemistry	2011	97
Nanostructured lipid carriers as oral delivery systems for poorly soluble drugs Ana Beloqui, Ana del Pozo‐Rodríguez, Alicia Rodríguez‐Gascón, Journal of Drug Delivery Science and Technology NanoparticlesNanomedicineEngineeringSoluble DrugsMedicine	2017	90
Dextran–protamine–solid lipid nanoparticles as a non-viral vector for gene therapy: In vitro characterization and in vivo transfection after intravenous administration to mice Diego Delgado, Alicia Rodríguez‐Gascón, Ana del Pozo‐Rodríguez, International Journal of Pharmaceutics NanoparticlesNanomedicineGene TherapiesEngineeringMedicine	2012	89
Structural recovery of the retina in a retinoschisin-deficient mouse after gene replacement therapy by solid lipid nanoparticles Paola S. Apaolaza, Ana del Pozo‐Rodríguez, Maria Ángelés Solinís, Biomaterials NanomedicineStructural RecoveryPhotoreceptor CellEngineeringRetina	2016	89

Page 1